Mohammed Basabrain

6PUBLICATIONS
14CO-AUTHORS
Innate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2026
Cost-Effective and Time-Saving Multiplex-Beads Immunoassay Method to Detect Humoral Immune Responses Against Respiratory Infections.

|May 13, 2026
Novel NSAID Analogs Exhibit Anti-Leukemic Activity Through Modulation of Apoptotic and Survival Pathways.

|Nov 13, 2025
Correction: Alzahrani et al. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

|Aug 14, 2025
Investigating the Potential of Propranolol as an Anti-Tumor Agent in Colorectal Cancer Cell Lines.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

|Jul 10, 2025
A narrative review of research advancements in pharmacogenetics of cardiovascular disease and impact on clinical implications.

Ayat Shorbaji, Peter Natesan Pushparaj, Ayat B Al-Ghafari

|May 14, 2025
Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

Pageof 1

Frequent Collaborators

4 joint publications

Shiekhah Mohammad Alzahrani

4 joint publications

Hind Ali Alkhatabi

3 joint publications

Huda Abdulaziz Al Doghaither

2 joint publications

Peter Natesan Pushparaj